#Pharma #Bourse Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA (lubiprostone) http://t.co/7AnOXamTOa
July 03, 2013
Publicité
/http%3A%2F%2Fwww.businesswire.com%2Fimages%2Fbwlogo_web.jpg)
BETHESDA, Md.--()--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that it has received a $10 million milestone payment from Takeda Pharmaceutical Company Limited (Takeda), pursuant to the existing collaboration and license agreement between SPI and Takeda.